# Antipsychotics and Metabolic Syndrome

> **NCT00636753** · — · SUSPENDED · sponsor: **Glostrup University Hospital, Copenhagen** · enrollment: 60 (estimated)

## Conditions studied

- Metabolic Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00636753
- **Lead sponsor:** Glostrup University Hospital, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2008-09
- **Primary completion:** 2009-07
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** this study has not finding place
- **Last updated:** 2010-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00636753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00636753, "Antipsychotics and Metabolic Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00636753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*